Avalo Therapeutics, Inc. (AVTX)

NASDAQ: AVTX · Real-Time Price · USD

7.76

+0.06 (0.78%)

At close: Nov 13, 2026, 4:00 PM EST

7.55

-0.21 (-2.71%)

After-hours: Nov 13, 2026, 7:30 PM EST

Avalo Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	449	329	78	7	47	191
Market Cap Growth	60.37%	323.58%	965.79%	-84.63%	-75.15%	-95.47%
Enterprise Value	56	218	-1	-1	52	153
Last Close Price	7.76	18.16	7.43	9.10	1209.61	4895.96

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	7605.21	5581.57	176.29	3.79	2.63	35.37
PB Ratio	0.96	3.97	0.58	1.00	-4.35	8.27
P/TBV Ratio	1.05	4.54	0.63	-	-	22.11

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	947.36	3699.17	-	-	2.87	28.36

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0	0.01	0.01	0.26	-1.98	1.53
Net Debt / Equity Ratio	-0.90	-1.18	-1.00	-0.75	-0.78	-0.83
Net Debt / EBITDA Ratio	4.11	1.35	3.28	0.24	-0.28	0.24
Net Debt / FCF Ratio	6.19	1.90	2.72	0.18	-0.32	0.27
Asset Turnover	0	0	0.01	0.07	0.32	0.09
Inventory Turnover	-	-	-	-	896.21	2444.83
Quick Ratio	16.31	7.60	19.33	1.64	0.68	2.99
Current Ratio	16.63	8.14	19.95	1.82	0.74	3.11
Return on Equity (ROE)	-33.58%	-72.44%	-50.06%	-	-684.77%	-354.08%
Return on Assets (ROA)	-19.69%	-34.12%	-29.75%	-53.91%	-32.95%	-82.82%
Return on Invested Capital (ROIC)	-206.93%	-	-	-359.43%	-396.92%	-1501.54%
Return on Capital Employed (ROCE)	-20.90%	-70.40%	-28.40%	-143.20%	-266.10%	-136.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-33.27%	-23.76%	-45.18%	-432.43%	-87.80%	-44.19%
FCF Yield	-14.14%	-15.63%	-63.10%	-422.75%	-56.58%	-37.19%
Buyback Yield / Dilution	-201.16%	-78.82%	-2599.19%	-608.45%	-8.32%	-41.86%

SEC Filings: 10-K · 10-Q